BARDA, AMCG hold stakeholder conference

The U.S. Biomedical Advanced Research and Development Authority and the Office of Acquisitions Management, Contracts and Grants recently held a public forum for emergency preparedness and public health stakeholders.

BARDA Industry Day 2012, "Contracting for Countermeasures," was an opportunity for the agencies to discuss U.S. government medical countermeasures development requirements and network with colleagues in the private sector.

Both BARDA and AMCG are components of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response.

MCMs are used to protect soldiers and civilians from the effects of chemical, biological, radiological and nuclear WMD threats, pandemic influenza and emerging infectious diseases. BARDA is responsible for supporting the advanced research, development, manufacturing and stockpiling of MCMs, which include drugs, biological therapeutics, vaccines and diagnostics.

The first day of the conference introduced BARDA's core programs and services to attendees. Sessions on the development of new antimicrobials and MCMs for pediatric and special populations were also included.

The second day consisted primarily of an interactive workshop in the U.S. government contracting process. The workshop introduced attendees to how the government determines and establishes its requirements, issues awards, develops solicitations and evaluates proposals.

Attendees were encouraged to request one-on-one meetings with BARDA or AMCG staff that were scheduled for the conference's third day.